Eutecma's Tempaid buy pairs reusable bulk shippers with last-mile mailers as smaller, more frequent refrigerated shipments reshape demand.
|Articles|August 29, 2014
- Pharmaceutical Commerce - September/October 2014
2014 Cold Chain Directory
Our annual compilation of key vendors and service providers in this vital component of pharmaceutical distribution, together with a preview of the IQPC Cold Chain Forum and more late-breaking news
Advertisement
Articles in this issue
about 12 years ago
A conversation with Seyed Mortazavi, IMS Healthabout 12 years ago
PBM formulary exclusion lists continue to growabout 12 years ago
Catalent goes public in a successful IPOabout 12 years ago
EvaluatePharma forecast: 2020 global pharma sales of $1.107 trillionabout 12 years ago
Agency rides the rare-disease waveabout 12 years ago
Legal uncertainties in the DSCSAabout 12 years ago
Is tech running you? Four ways to retake controlAdvertisement
Related to this article
Copeland's Dickson buy adds cloud-native monitoring as the pharma cold chain moves toward continuous visibility to meet rising regulatory demands.
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Waltz Health, Fresenius Kabi Are Taking Biosimilars Direct
2
Why Retail Pharmacy’s Trust Challenge Is Also Its Path Forward
3
GLP-1 Payment Risks: What Pharmacies Should Review with Their Processor
4
Cold Chain Consolidation Continues as Eutecma Acquires Tempaid
5